M. Toyota, H. Suzuki, T. Yamashita, K. Hirata, K. Imai et al., Cancer epigenomics: Implications of DNA methylation in personalized cancer therapy, Cancer Science, vol.39, issue.5, pp.787-791, 2009.
DOI : 10.1111/j.1349-7006.2009.01095.x

M. Mccabe, J. Brandes, and P. Vertino, Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications, Clinical Cancer Research, vol.15, issue.12, pp.3927-3937, 2009.
DOI : 10.1158/1078-0432.CCR-08-2784

J. Costello, M. Frühwald, D. Smiraglia, L. Rush, G. Robertson et al., Aberrant CpG-island methylation has non-random and tumour-type???specific patterns, Nature Genetics, vol.196, issue.2, pp.132-138, 2000.
DOI : 10.1038/72785

S. Maier, C. Dahlstroem, C. Haefliger, A. Plum, and C. Piepenbrock, Identifying DNA Methylation Biomarkers of Cancer Drug Response, American Journal of PharmacoGenomics, vol.20, issue.4, pp.223-232, 2005.
DOI : 10.2165/00129785-200505040-00003

M. Hegi, A. Diserens, T. Gorlia, M. Hamou, N. De-tribolet et al., Gene Silencing and Benefit from Temozolomide in Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.997-1003, 2005.
DOI : 10.1056/NEJMoa043331

R. Noro, A. Gemma, A. Miyanaga, S. Kosaihira, Y. Minegishi et al., PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors, Int J Oncol, vol.31, pp.1157-1163, 2007.

M. Hegi, D. Sciuscio, A. Murat, M. Levivier, and R. Stupp, Epigenetic Deregulation of DNA Repair and Its Potential for Therapy, Clinical Cancer Research, vol.15, issue.16, pp.5026-5031, 2009.
DOI : 10.1158/1078-0432.CCR-08-1169

I. Caceres, M. Cortes-sempere, C. Moratilla, R. Machado-pinilla, V. Rodriguez-fanjul et al., IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer, Oncogene, vol.61, issue.11, pp.1681-1690, 2010.
DOI : 10.1186/1476-4598-3-14

T. Seng, N. Currey, W. Cooper, C. Lee, C. Chan et al., DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma, British Journal of Cancer, vol.61, issue.2, pp.375-382, 2008.
DOI : 10.1038/sj.onc.1205835

T. Taniguchi, M. Tischkowitz, N. Ameziane, S. Hodgson, C. Mathew et al., Disruption of the Fanconi anemia???BRCA pathway in cisplatin-sensitive ovarian tumors, Nature Medicine, vol.9, issue.5, pp.568-574, 2003.
DOI : 10.1038/nm852

S. Leng, K. Do, C. Yingling, M. Picchi, H. Wolf et al., Defining a Gene Promoter Methylation Signature in Sputum for Lung Cancer Risk Assessment, Clinical Cancer Research, vol.18, issue.12, pp.3387-3395, 2012.
DOI : 10.1158/1078-0432.CCR-11-3049

M. Brock, C. Hooker, E. Ota-machida, Y. Han, M. Guo et al., DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer, New England Journal of Medicine, vol.358, issue.11, pp.1118-1128, 2008.
DOI : 10.1056/NEJMoa0706550

J. Sandoval, J. Mendez-gonzalez, E. Nadal, G. Chen, F. Carmona et al., A Prognostic DNA Methylation Signature for Stage I Non???Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.31, issue.32, pp.4140-4147, 2013.
DOI : 10.1200/JCO.2012.48.5516

D. Sproul, C. Nestor, J. Culley, J. Dickson, J. Dixon et al., Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer, Proceedings of the National Academy of Sciences, vol.108, issue.11, pp.4364-4369, 2011.
DOI : 10.1073/pnas.1013224108

D. Swafford, S. Middleton, W. Palmisano, K. Nikula, J. Tesfaigzi et al., Frequent aberrant methylation of p16INK4a in primary rat lung tumors., Molecular and Cellular Biology, vol.17, issue.3, pp.1366-1374, 1997.
DOI : 10.1128/MCB.17.3.1366

K. Shedden, J. Taylor, S. Enkemann, M. Tsao, T. Yeatman et al., Gene expression???based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study, Nature Medicine, vol.92, issue.8, pp.14822-827, 2008.
DOI : 10.1038/nm.1790

A. Subramanian, A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.10215545-15550, 2005.
DOI : 10.1073/pnas.0506580102

J. Yang and R. Weinberg, Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis, Developmental Cell, vol.14, issue.6, pp.818-829, 2008.
DOI : 10.1016/j.devcel.2008.05.009

M. Lombaerts, T. Van-wezel, K. Philippo, J. Dierssen, R. Zimmerman et al., E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines, British Journal of Cancer, vol.14, pp.661-671, 2006.
DOI : 10.1016/j.cell.2004.06.006

N. Dumont, M. Wilson, Y. Crawford, P. Reynolds, M. Sigaroudinia et al., Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers, Proceedings of the National Academy of Sciences, vol.105, issue.39, pp.14867-14872, 2008.
DOI : 10.1073/pnas.0807146105

H. Cheng, T. Fukushima, N. Takahashi, H. Tanaka, and H. Kataoka, Hepatocyte Growth Factor Activator Inhibitor Type 1 Regulates Epithelial to Mesenchymal Transition through Membrane-Bound Serine Proteinases, Cancer Research, vol.69, issue.5, pp.1828-1835, 2009.
DOI : 10.1158/0008-5472.CAN-08-3728

A. Singh, P. Greninger, D. Rhodes, L. Koopman, S. Violette et al., A Gene Expression Signature Associated with ???K-Ras Addiction??? Reveals Regulators of EMT and Tumor Cell Survival, Cancer Cell, vol.15, issue.6, pp.489-500, 2009.
DOI : 10.1016/j.ccr.2009.03.022

C. Warzecha, T. Sato, B. Nabet, and J. Hogenesch, ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing, Molecular Cell, vol.33, issue.5, pp.591-601, 2009.
DOI : 10.1016/j.molcel.2009.01.025

Z. Zhang, J. Lee, L. Lin, V. Olivas, V. Au et al., Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer, Nature Genetics, vol.88, issue.8, pp.852-860, 2012.
DOI : 10.2353/jmoldx.2010.090140

L. Byers, L. Diao, J. Wang, P. Saintigny, L. Girard et al., An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance, Clinical Cancer Research, vol.19, issue.1, pp.279-290, 2012.
DOI : 10.1158/1078-0432.CCR-12-1558

X. Ke, W. Li, R. Hovland, Y. Qu, R. Liu et al., Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model, Experimental Cell Research, vol.317, issue.2, pp.234-247, 2011.
DOI : 10.1016/j.yexcr.2010.10.009

S. Thomson, F. Petti, I. Sujka-kwok, P. Mercado, J. Bean et al., A systems view of epithelial???mesenchymal transition signaling states, Clinical & Experimental Metastasis, vol.15, issue.19, pp.137-155, 2011.
DOI : 10.1007/s10585-010-9367-3

S. Mani, W. Guo, M. Liao, E. Eaton, A. Ayyanan et al., The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells, Cell, vol.133, issue.4, pp.704-715, 2008.
DOI : 10.1016/j.cell.2008.03.027

E. Cerami, E. Demir, N. Schultz, B. Taylor, and C. Sander, Automated Network Analysis Identifies Core Pathways in Glioblastoma, PLoS ONE, vol.5, issue.2, 2010.
DOI : 10.1371/journal.pone.0008918.g005

E. Dijkstra, A note on two problems in connexion with graphs, Numerische Mathematik, vol.4, issue.1, pp.269-271, 1959.
DOI : 10.1007/BF01386390

D. Shames, L. Girard, B. Gao, M. Sato, C. Lewis et al., A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies, PLoS Medicine, vol.125, issue.12, p.486, 2006.
DOI : 10.1371/journal.pmed.0030486.st005

G. Heller, V. Babinsky, B. Ziegler, M. Weinzlerl, C. Noll et al., Genome-wide CpG island methylation analyses in non-small cell lung cancer patients, Carcinogenesis, vol.34, issue.3, pp.513-521, 2013.
DOI : 10.1093/carcin/bgs363

R. Yauch, T. Januario, D. Eberhard, G. Cavet, W. Zhu et al., Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients, Clinical Cancer Research, vol.11, issue.24, pp.8686-8698, 2005.
DOI : 10.1158/1078-0432.CCR-05-1492

S. Thomson, E. Buck, F. Petti, G. Griffin, E. Brown et al., Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non-Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition, Cancer Research, vol.65, issue.20, pp.9455-9462, 2005.
DOI : 10.1158/0008-5472.CAN-05-1058

E. Kim, W. Hong, J. Lee, L. Mao, R. Morice et al., Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers, Cancer Prevention Research, vol.3, issue.2, pp.148-159, 2010.
DOI : 10.1158/1940-6207.CAPR-09-0233

K. Gold, E. Kim, J. Lee, I. Wistuba, C. Farhangfar et al., The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration, Cancer Prevention Research, vol.4, issue.7, pp.962-972
DOI : 10.1158/1940-6207.CAPR-11-0232

P. Jones and S. Baylin, The Epigenomics of Cancer, Cell, vol.128, issue.4, pp.683-692, 2007.
DOI : 10.1016/j.cell.2007.01.029

R. Lister, M. Pelizzola, R. Dowen, R. Hawkins, G. Hon et al., Human DNA methylomes at base resolution show widespread epigenomic differences, Nature, vol.10, issue.7271, pp.315-322, 2009.
DOI : 10.1038/nature08514

T. Kiziltepe, T. Hideshima, L. Catley, N. Raje, H. Yasui et al., 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells, Molecular Cancer Therapeutics, vol.6, issue.6, pp.1718-1727, 2007.
DOI : 10.1158/1535-7163.MCT-07-0010

M. Wales, M. Biel, W. Deiry, B. Nelkin, J. Issa et al., activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13, Nat Med, vol.3, issue.1, pp.53570-577, 1995.

W. Zhang, S. Glöckner, M. Guo, E. Machida, D. Wang et al., Epigenetic Inactivation of the Canonical Wnt Antagonist SRY-Box Containing Gene 17 in Colorectal Cancer, Cancer Research, vol.68, issue.8, pp.2764-2772, 2008.
DOI : 10.1158/0008-5472.CAN-07-6349

K. Walter, T. Holcomb, T. Januario, P. Du, M. Evangelista et al., DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non-Small Cell Lung Cancer, Clinical Cancer Research, vol.18, issue.8, pp.2360-2373, 2012.
DOI : 10.1158/1078-0432.CCR-11-2635-T

O. Mcdonald, H. Wu, W. Timp, A. Doi, and A. Feinberg, Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition, Nature Structural & Molecular Biology, vol.18, issue.8, pp.867-874, 2011.
DOI : 10.1016/j.ymeth.2006.07.030

A. Montero, C. Díaz-montero, L. Mao, E. Youssef, M. Estecio et al., Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer, Cancer Biology & Therapy, vol.5, issue.11, pp.1494-1501, 2006.
DOI : 10.4161/cbt.5.11.3299

M. Chen, Y. Xie, and M. Story, An Exponential-Gamma Convolution Model for Background Correction of Illumina BeadArray Data, Communications in Statistics - Theory and Methods, vol.5, issue.17, pp.3055-3069, 2011.
DOI : 10.1093/bioinformatics/btp040

L. Ding, Y. Xie, S. Park, X. G. Story, and M. , Enhanced identification and biological validation of differential gene expression via Illumina whole-genome expression arrays through the use of the model-based background correction methodology, Nucleic Acids Research, vol.36, issue.10, 2008.
DOI : 10.1093/nar/gkn234

S. Colella, L. Shen, K. Baggerly, J. Issa, and R. Krahe, Sensitive and quantitative universal Pyrosequencing? methylation analysis of CpG sites, BioTechniques, vol.35, pp.146-150, 2003.

M. Smoot, K. Ono, J. Ruscheinski, P. Wang, and T. Ideker, Cytoscape 2.8: new features for data integration and network visualization, Bioinformatics, vol.27, issue.3, pp.431-432, 2010.
DOI : 10.1093/bioinformatics/btq675

. Lin, Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial???mesenchymal transition, BMC Genomics, vol.15, issue.1, p.1079, 2014.
DOI : 10.1093/nar/gkn234
URL : https://hal.archives-ouvertes.fr/inserm-01122392